Therapy with urolithin A restores mitophagy in DMD worms and mice, as well as in primary myoblasts from DMD patients, thereby restoring muscle function and improving survival in the DMD mouse model
It protects inflamed tissue and reduces swelling caused by bruises, sprains, strains, tendonitis, and haematomas (not on the skin)
Medical disclaimer: This article is for informational purposes only and is not medical advice
These proteins usually lack a clearly defined binding bag or enzyme domain, preventing the participation of stable inhibitors, thus limiting the development of treatment [1,2,3]
When people start researching BPC-157, they usually want one clear answer: Should I choose capsules or injections